Koura wins Innovation Award for new ‘green’ medical propellant

Global leader in medical propellants, Koura, has been recognised at the Chemical Northwest Awards for Innovation for its new Zephex® 152a medical propellant.  Koura’s work in innovation is being celebrated for its development of a low-carbon medical propellant, Zephex® 152a. Pressurized metered-dose-inhalers (pMDI) using Zephex® 152a will bring about a greater than 90 percent reduction in the carbon…

Read More

Koura announces major investment into new ‘greener’ medical propellant production facility in United Kingdom

Koura announces a multimillion-pound sterling investment into a new cGMP Zephex® 152a medical propellant production facility at their Runcorn, UK location. This investment is part of a program to bring Zephex® 152a from the laboratory to the patient and will provide a scaling-up in production…

Read More

Koura Donates 10,000 Inhalers to the Government of Maharashtra, India (Haffkine Institute)

Koura, part of Orbia Advance Corporation S.A.B. de C.V. (BMV: ORBIA*), makes a successful donation delivery of 10,000 medical grade inhalers to the Government of Maharashtra, India. The delivery of these inhalers will help Indian authorities maintain critical equipment supplies at a time when need…

Read More

Koura announces major investment into new ‘greener’ medical propellant production facility in United Kingdom

Koura announces a multi million-pound sterling investment into a new cGMP Zephex® 152a medical propellant production facility at their Runcorn, UK location. This investment is part of a program to bring Zephex® 152a from the laboratory to the patient and will provide a scaling-up in…

Read More

A Day in the Life…Claire McGuinness

We spoke to Claire McGuinness, Technical Support Manager for Koura about her experience of being a woman in STEM. 

Read More

‘GREEN’ MEDICAL PROPELLANT RECEIVES FDA APPROVAL TO PROCEED TO CLINICAL TRIALS

BOSTON, Feb. 4, 2020 – Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use…

Read More

Third student awarded the Koura Alasdair Sinclair Scholarship

The University of Manchester has announced Melissa Pace as the third student to receive Koura’s Alasdair Sinclair Scholarship.

Read More

Mexichem Fluor showcases courageous new identity

Our parent company has rebranded as Koura to reflect our bold, diverse and progressive new direction as a business. Find out more here.

Read More